Left Ventricular Ejection Fraction Improvement and Ventricular Arrhythmia Risk in Patients With Heart Failure

Toshihiro Nakamura1, Kohei Ishibashi1, Nobuhiko Ueda1

  • 1Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Insights

Implantable cardioverter defibrillators (ICDs) help prevent sudden cardiac death. Even with improved heart function (LVEF recovery), some patients may still need ICD therapy, indicating personalized management is key.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Implantable cardioverter defibrillators (ICDs) are crucial for preventing sudden cardiac death in heart failure patients.
  • The efficacy of ICDs after recovery of left ventricular ejection fraction (LVEF) remains uncertain.

Purpose of the Study:

  • To evaluate the long-term outcomes of primary prevention ICD therapy in patients who experience LVEF recovery.

Main Methods:

  • Retrospective analysis of 118 patients receiving primary prevention ICDs between 2013 and 2022.
  • Patients were categorized based on LVEF improvement (impEF: LVEF >35%) versus persistently low LVEF.

Main Results:

  • 34% of patients (40/118) achieved improved LVEF (impEF).
  • The impEF group experienced significantly less appropriate ICD therapy (P=0.008) over 4.4 years.
  • However, 4 impEF patients required antitachycardia pacing; no patient with LVEF ≥40% received therapy.

Conclusions:

  • LVEF recovery significantly reduces ventricular arrhythmia risk in ICD patients.
  • Risk is not eliminated, underscoring the need for individualized ICD management strategies.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
198
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
668
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
362
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
421